167 related articles for article (PubMed ID: 25989801)
21. Complete Resolution of Metastatic Gallbladder Cancer after Standard Gemcitabine-Cisplatin Combination Therapy.
Rho YS; Barrera I; Metrakos P; Kavan P
Cureus; 2015 Dec; 7(12):e415. PubMed ID: 26848408
[TBL] [Abstract][Full Text] [Related]
22. Targeted Therapies in Trial for Non-Resectable Gallbladder Cancer.
Nasrallah AA; Khachfe HH; Salhab HA; Fares MY; Fares J
J Gastrointest Cancer; 2021 Jun; 52(2):515-522. PubMed ID: 32394022
[TBL] [Abstract][Full Text] [Related]
23. Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; Sottotetti E; Martinetti A; Busset MDD; Sposito C; Di Bartolomeo M; Pietrantonio F; de Braud F; Mazzaferro V
BMC Cancer; 2024 May; 24(1):563. PubMed ID: 38711003
[No Abstract] [Full Text] [Related]
24. Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy: A Case Report and Review of the Literature.
Wiesweg M; Aydin S; Koeninger A; Stein A; Schara U; van Roye C; Hense J; Welt A; Schuler M
AJP Rep; 2014 May; 4(1):17-22. PubMed ID: 25032054
[TBL] [Abstract][Full Text] [Related]
25. Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
Bridgewater J; Lopes A; Beare S; Duggan M; Lee D; Ricamara M; McEntee D; Sukumaran A; Wasan H; Valle JW
BMC Cancer; 2016 Jun; 16(1):369. PubMed ID: 27328670
[No Abstract] [Full Text] [Related]
26. Reversal of jaundice in two patients with inoperable cholangiocarcinoma treated with Cisplatin and gemcitabine combination.
Criel M; Geurs F; Ponette S; Bulte K; Ponette J
Case Reports Hepatol; 2012; 2012():138381. PubMed ID: 25954551
[TBL] [Abstract][Full Text] [Related]
27. Pemigatinib (Pemazyre) for cholangiocarcinoma.
Med Lett Drugs Ther; 2018 May; 60(1546):e208-e209. PubMed ID: 33451178
[No Abstract] [Full Text] [Related]
28. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.
Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H
BMC Cancer; 2015 Jul; 15():564. PubMed ID: 26228433
[TBL] [Abstract][Full Text] [Related]
29. Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer.
Watanabe A; Kida M; Miyazawa S; Iwai T; Okuwaki K; Kaneko T; Yamauchi H; Takezawa M; Imaizumi H; Koizumi W
World J Gastroenterol; 2015 May; 21(19):5979-84. PubMed ID: 26019463
[TBL] [Abstract][Full Text] [Related]
30. [Gemcitabine in Combination with Cisplatin in Patients with Unresectable Advanced or Recurrent Biliary Tract Cancer--A Multicenter Prospective Observational Study in Fukuoka].
Yamashita Y; Sirabe K; Kawabe K; Fujimori N; Hisano T; Okabe Y; Akiyama T; Ueki T; Horiuchi H; Yamaguchi H; Ito T; Suga H; Funakosi A
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1185-9. PubMed ID: 26489546
[TBL] [Abstract][Full Text] [Related]
31. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
Zhu AX; Park JO; Ryoo BY; Yen CJ; Poon R; Pastorelli D; Blanc JF; Chung HC; Baron AD; Pfiffer TE; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang SC; Abada PB; Yang L; Schwartz JD; Kudo M;
Lancet Oncol; 2015 Jul; 16(7):859-70. PubMed ID: 26095784
[TBL] [Abstract][Full Text] [Related]
32. Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).
Park YH; Jung KH; Im SA; Sohn JH; Ro J; Ahn JH; Kim SB; Nam BH; Oh DY; Han SW; Lee S; Park IH; Lee KS; Kim JH; Kang SY; Lee MH; Park HS; Woo SY; Jung SH; Ahn JS; ; Im YH
Breast Cancer Res Treat; 2015 Jul; 152(1):77-85. PubMed ID: 26033708
[TBL] [Abstract][Full Text] [Related]
33. A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
Ramalingam S; Goss G; Rosell R; Schmid-Bindert G; Zaric B; Andric Z; Bondarenko I; Komov D; Ceric T; Khuri F; Samarzija M; Felip E; Ciuleanu T; Hirsh V; Wehler T; Spicer J; Salgia R; Shapiro G; Sheldon E; Teofilovici F; Vukovic V; Fennell D
Ann Oncol; 2015 Aug; 26(8):1741-8. PubMed ID: 25997818
[TBL] [Abstract][Full Text] [Related]
34. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
[TBL] [Abstract][Full Text] [Related]
35. Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.
Oyasiji T; Zhang J; Kuvshinoff B; Iyer R; Hochwald SN
Oncologist; 2015 Jul; 20(7):742-51. PubMed ID: 26025932
[TBL] [Abstract][Full Text] [Related]
36. Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies.
Rixe O; Puzanov I; LoRusso PM; Cohen RB; Morris JC; Olowokure OO; Yin JY; Doroumian S; Shen L; Olszanski AJ
Anticancer Drugs; 2015 Aug; 26(7):785-92. PubMed ID: 26020806
[TBL] [Abstract][Full Text] [Related]
37. Bilateral subdural hygromas following administration of intrathecal methotrexate chemotherapy.
Lewis H; Mahdi AJ; Rowntree C
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26002663
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer.
Kim HS; Ryu MH; Zang DY; Ryoo BY; Yang DH; Cho JW; Lim MS; Kim MJ; Han B; Choi DR; Kim JH; Jung JY; Song H; Park CK; Kang YK
Gastric Cancer; 2016 Apr; 19(2):579-585. PubMed ID: 25997815
[TBL] [Abstract][Full Text] [Related]
39. [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy].
Kuga Y; Moriya T; Fukuda S; Nishida T
Gan To Kagaku Ryoho; 2016 Jun; 43(6):773-5. PubMed ID: 27306819
[TBL] [Abstract][Full Text] [Related]
40. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
